finance.yahoo.com
· Sep 8, 2026 2:13 PM EDT
Not market news
Why the CNS boom owes its success to breakthroughs in neurological pathologies
Shifting emphasis from symptoms to biomarkers has bolstered sector confidence in emerging CNS therapies.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
